Recent experimental data have revealed that activins and inhibins exert pivotal effects on development. As part of our studies on growth and differentiation of the human fetal adrenal gland, we examined the subunit localization, as well as the mitogenic and steroidogenic actions of activin and inhibin in human fetal and adult adrenals. All three activin and inhibin subunit proteins (a, ,A, and #B) were detected in the fetal and adult adre- 
Introduction
Activin is a homodimeric glycoprotein structurally related to inhibin and other members of the transforming growth factorbeta (TGF-fl)' superfamily ofdevelopmentally significant peptides ( 1) . Although activin was originally isolated from the gonad and characterized because ofits ability to stimulate pituitary follicle-stimulating hormone (FSH) production (2) , it is becoming apparent that it has many key biologic functions. It is strongly conserved across species and may subserve different functions in the organism at different stages of development. Activin induces mesodermal formation in Xenopus (3), stimulates hematopoiesis in a variety ofspecies (4) (5) (6) , and can modulate the production of several pituitary trophic hormones (7) (8) (9) , in addition to modulating growth and hormonal production in the pituitary-gonadal axis (2) . Activins are fl-fl dimers ((A-(A or activin-A; 3A-3B or activin-AB), whereas inhibins are a-j heterodimers (a-#A or inhibin-A; a-B or inhibin-B).
The subunits ofactivin and inhibin are expressed in the adrenal gland of the rat ( 10) and of the fetal and adult sheep ( 11 ) , but information on their expression or actions in the human adrenal gland is lacking.
The human fetal adrenal gland consists of two histologically and functionally distinct zones. The outer definitive zone is regarded as the principal forerunner of the adult cortex and secretes mainly cortisol ( 12) . The inner fetal zone is unique to intrauterine life and comprises more than 80% of the fetal gland. The fetal zone grows rapidly in midgestation and produces large quantities of dehydroepiandrosterone sulfate (DHAS), a substrate for placental estrogen synthesis ( 12, 13) . Despite numerous studies on the development of the human fetal adrenal gland, the factors regulating growth and differentiation of the fetal adrenal cortex have not been completely defined.
We recently presented evidence that activin-A inhibits human fetal adrenal cell proliferation and modulates the proliferative effects of epidermal growth factor (EGF) and TGF-3 ( 14) .
In the present study, we examined the expression ofactivin and inhibin subunits in the human fetal and adult adrenal gland. We also investigated the presence of dimeric activin-A in fetal and neonatal adrenals. To provide insight into the regulation of these peptides in the adrenal cortex, we determined the effect of ACTH Subunit antibodies and monoclonal antibodies to activin-A. Antibodies to the a, fA, and 3B subunits were the generous gift of J. Vaughan and Dr. W. Vale, Peptide Biology Lab, The Salk Institute (La Jolla, CA). Each antiserum was produced in rabbits against synthetic inhibin fragments coupled to human a-globulins. Preparation and characterization of the antisera have been described in detail previously (16) (17) (18) .
Monoclonal antibodies specific for activin-A were the gift of Dr. Ralph Schwall, Genentech Inc. These antibodies were produced using the mutant hypogonadal (hpg) mouse (Jackson Laboratories, Bar Harbor, ME). Mice were hyperimmunized in the hind foot pad with 5-,ug doses of purified recombinant activin-A. Inguinal and popliteal node lymphocytes were fused with a mouse myeloma cell line, as described previously ( 19) . Production of antibodies by the resulting hybridomas was assessed by solid phase ELISA. Specificity was checked by a subsequent solid phase ELISA using inhibin-A as the coat antigen. Specificity was further characterized by testing for immunoprecipitation of metabolically labeled activin-A and inhibin-A, produced as described previously (20) . The antibody used in the present studies did not crossreact with inhibin using either ofthese methods. Cross-reactivity ofthe monoclonal antibody to activin-A with activin subunits was tested by Western blot. fA monomer was generated by reducing intact, dimeric activin-A with 5% fl-mercaptoethanol at 55°C for 60 min. Monoclonal antibody reacted with the intact activin-A dimer, showing a single band at 24 K, but there was no detectable band in the lane containing the monomeric subunit. As a positive control, polyclonal antiserum made against activin-A showed bands with both the intact dimer and the monomeric subunit. Thus, no cross-reactivity was observed between the monoclonal antibody for activin-A and either inhibin-A or ,BA monomer.
Histology and immunocytochemistry. Human adult (n = 6) and midtrimester fetal (n = 8) adrenal glands, as well as a human anencephalic adrenal gland specimen (n = 1), were fixed immediately at the time of necropsy in 4% paraformaldehyde and 0.15 M phosphate buffer and kept for 24-72 h at 40C. The tissue was then dehydrated in alcohol and embedded in paraffin. Serial sections (8 Mm thick) were mounted on gelatin-alum-coated glass slides. Slides were deparaffinized in graded ethanols and hydrated to 0.1 M Tris-buffered saline (TBS), pH 7.4, immediately before immunostaining.
Slides were pretreated with 0.01% sodium azide and 0.5% H202 for 20 min and with 3% normal goat serum in TBS containing 1% BSA for 10 min at room temperature to block nonspecific staining. Slides for subunit immunostaining were incubated with subunit antibodies for 2 h at room temperature at the following dilutions: 1) 1:200 antiporcine inhibin-f3A cyclized Ac-( 81-113)-NH2; 2) 1:500 antiporcine inhibin-a (1-26)-Gly-Tyr; and 3) 1:300 anti-human inhibin-fB cyclized Ac-(80-1 12)-NH2. Slides for activin-A immunostaining were incubated for 2-6 h with a monoclonal antibody raised against the activin-A dimer at a concentration of2-10 Ag! ml. Immunohistochemical staining was completed using the Vectastain Elite ABC Kit (Vector Laboratories, Inc., Burlingame, CA) with diaminobenzidine as the chromogen. Only faint uniform background was observed in control sections reacted either with absorbed antisera or with buffer in place of the primary antisera used. All sections were dehydrated in graded ethanols, cleared in xylene and mounted with Protexx (Scientific Products, McGraw Park, IL). Photographs were taken with Kodak Technical Pan film.
In situ hybridization. 35S-labeled antisense mRNA probes specific for human inhibin a, fA, and 3B were generated by transcription from the SP6 or T7 promoters oflinearized pGEM4 subclones ( 10, 21 ) . The human inhibin probe complementary to the a subunit comprised 1.3 kb of the full length a subunit. The human ,BA probe was 350 bp, including the final 73 amino acids at the COOH-terminus and a portion of the 3' untranslated region of the cDNA. The human ,BB probe was 1.8 kb, corresponding to amino acid 42 to the COOH-terminus and including approximately 800 bp of the 3' untranslated region. Background signal was determined using 3S-labeled sense RNA probes for inhibin a, fA, and fB.
Probes were applied at 55°C overnight in 50% formamide, 4X standard saline citrate (SSC), lx Denhardt's solution, 100 Mg/ml salmon sperm DNA, and 100 Mg/ml yeast tRNA. Slides were washed in 2x SSC at room temperature for 15 min and then 4 times for 15 min in 0.5x SSC at 550C. After RNAse treatment (20 Mg/ml), slides were washed with 2x SSC, dipped in photographic emulsion (Kodak NTB-2; Eastman Kodak Co., Rochester, NY), and exposed in light-tight boxes at 4°C for 7 d. Slides were developed (Kodak D-19 developer), rinsed in tap water, and counterstained with cresyl violet.
To study the effects of ACTH on activin/inhibin subunit mRNA accumulation, fetal adrenal cells were cultured on eight-chamber glass microscope slides (Lab-Tek Div. Miles Laboratories Inc., Nunc, Naperville, IL) at a density of 10,000 cells/chamber. After 48 h, the cells were stimulated for 24 h with either ACTH ( 10 nM) or 8-Br-cAMP ( 1 mM). The cells were then fixed in 4% paraformaldehyde and subjected to in situ hybridization using 35S-labeled a, flA, or flB subunit riboprobes, as described above.
RIA ofthe a-inhibin chain. RIA ofthe inhibin-a subunit in culture medium was performed as previously described by Vaughan et al. ( 18) , except that DSER 'Nle5 human inhibin-a( 1-25) served as standard and was used as tracer following radiolabeling with 125I and purification by HPLC. Inhibin levels are expressed in terms ofhighly purified 32 kD ovine inhibin-A. The sensitivity of the RIA was 5.7±4.0 fmol/tube. Steroid RIA. DHAS was measured directly from conditioned medium as previously described (22) . Cortisol was measured from etherextracted medium by RIA as described previously (23) . 
Results
Immunohistochemical localization ofactivin and inhibin subunits in human fetal and adult adrenals. Immunohistochemical staining ofmidgestation fetal adrenals revealed the presence of a, ,A, and ,BB subunits in scattered cells in both the fetal and definitive zones of the cortex. Distribution and staining intensity were similar for all three subunits; a representative example showing a subunit staining is shown in Fig. I A. Medullary cells did not exhibit subunit immunostaining. An adrenal gland from an anencephalic 20-wk human fetus, which demonstrated the characteristic cortical atrophy of both fetal and definitive zones, was also subjected to immunohistochemical staining (Fig. 1 B) . This specimen showed markedly decreased subunit staining intensity relative to the normal midgestation adrenals.
In adult adrenal glands, immunoreactive a, ,BA, and #B subunits were noted primarily in scattered cells in the zonae glomerulosa and fasciculata. A representative section of adult adrenal immunostained with antibody to a subunit is shown in Fig. 1 D. As in the fetal adrenal, no immunostaining was present in the medulla.
Immunoreactive activin-A dimer is present infetal and neonatal adrenals. Using antibody specific for intact activin-A ((BA-#A dimer), immunostaining of midtrimester fetal and neonatal adrenal glands demonstrated the presence of activin-A in the outer cortex. An example of the activin-A staining pattern seen in a neonatal adrenal is depicted in Fig. 1 C. The pattern of distribution was similar in fetus and neonate in that scattered positive cells occurred predominantly in the outer third of the cortex.
In situ hybridization ofactivin and inhibin subunit messenger RNAs. mRNAs for a, ,3A, and #lB subunits were detected in fetal adrenal sections, in both the definitive and the fetal zones, and in cultured fetal zone cells (f#A shown in Fig. 2 Secretion ofa subunit byfetal and adult adrenal cells. Basal a inhibin secretion over 48 h by cultured fetal zone cells was assayable near the detection limit of the assay (44 fmol/ml) whereas basal definitive zone a subunit secretion was present at slightly higher levels (mean: 234±20 fmol/ml per 100,000 cells). Addition of ACTH (10-6 to 10-10 M) to the culture medium of both fetal and definitive zone cells for 48 h before harvesting yielded a dose-dependent increase in the levels of secreted a subunit (Fig. 4) . Addition of 1 mM 8-Br-cAMP similarly increased a subunit secretion (Fig. 4) . Fresh culture medium (Ml99/Ham's F-12 medium with 10% FCS) contained no detectable a chain by RIA. Adult adrenal cells under basal conditions secreted low but detectable levels of a inhibin (52±13 fmol/ml per 100,000 cells). Addition of 10 nM ACTH to adult cell dispersions for 48 h before harvesting caused a fivefold increase in secreted radioimmunoassayable a-inhibin (Fig. 4) .
The peptide growth factors EGF, FGF, and TGF-# also were tested for their ability to stimulate a-inhibin secretion. At doses known to inhibit (TGF-fl) ( 14, 24) Fig. 5 A demonstrates the decrease in fetal zone cell number after 1-4 d exposure to activin-A (d 3-6 of culture). Activin-A had no significant effect on definitive zone (Fig. 5 B) or adult (Fig. 5 C) Activin-A enhances ACTH-stimulated cortisol production byfetal zone cells. Rh-activin-A in doses 2 1O ng/ml (400 pM) significantly increased ACTH-stimulated secretion of cortisol had no effect on basal or ACTH-stimulated fetal adrenal steroidogenesis (cortisol or DHAS secretion). In human adult adrenal cell dispersions, neither activin nor inhibin, alone or in combination, affected basal or ACTH-stimulated cortisol secretion (Fig. 6 ). However, these adult cultures were capable of responding to ACTH (10 nM) with a twofold increase in secreted cortisol.
Discussion
Evidence is accumulating for a pivotal role for activins and inhibins during development. Recent work has demonstrated mesodermal induction by activin in Xenopus embryos (3). Activin and inhibin subunit mRNAs are widely expressed in the developing rat embryo in endocrine and nonendocrine tissues (gonads, brain, and integumentary derivatives) (27) . The human placenta also expresses activin and inhibin subunit mRNAs, and in vitro, activin increased gonadotropin-releasing hormone (GnRH) and progesterone production, and it potentiated the GnRH-induced release of chorionic gonadotropin from cultured placental cells (28) . Thus, activins and inhibins have been implicated in the endocrine physiology of pregnancy.
The data presented here indicate that activin and inhibin subunit proteins and their mRNAs are expressed in the midtrimester human fetal adrenal gland, and that the subunit proteins also are present in the adult adrenal gland. In the adrenal gland from an anencephalic fetus (which was deficient in pituitary ACTH), subunit immunostaining was markedly dimin- these peptides in the adult adrenal, if any, remains to be elucidated. The actions of activin-A on fetal but not adult adrenal cell growth and steroidogenesis suggest a developmental role for this peptide in the immature human adrenal gland. Postnatally, the fetal zone undergoes involution and/or remodeling. The adult zonae glomerulosa, fasciculata, and reticularis are formed from the definitive cortex with an undefined contribution from maturational changes in the fetal zone (29) . A primate fetal zone transformation to form part of the adult cortex has been proposed previously (30, 31 ) . The ACTH-induced shift from primarily DHAS production to increased cortisol production in the fetal zone is analogous to the shift in steroidogenesis that occurs postnatally. Activin (33) . This difference may reflect species-specific, organ-specific, and/or developmentally dependent regulation ofsubunit production.
Using immunohistochemistry with an antibody to dimeric activin, we have demonstrated the presence of activin-A dimer in the fetal and neonatal adrenal. However, it is not possible to make definitive conclusions regarding synthesis of intact inhibin by the fetal adrenal, as the immunohistochemical signal for a-inhibin may represent isolated a subunit production. In addition, it is known that the RIA utilized to assess a subunit secretion also recognizes monomeric a subunit and the posttranslationally processed subunit, Pro-a, (34) . None of these products of pro-a subunit posttranslational processing has inhibin bioactivity (i.e., FSH-suppressing activity) in the in vitro rat pituitary cell bioassay (35, 36) . Nevertheless, given in situ production of both a and # subunits, the human fetal adrenal gland does have the potential for synthesis ofthe intact inhibin dimer. Use of antibody probes to the intact inhibin dimer, when available, should clarify this issue.
Rh-inhibin-A had no apparent mitogenic action or effect on cortisol or DHAS production in our adrenal culture system. The rh-inhibin-A used in our experiments was biologically active in a pituitary dispersion bioassay (i.e., inhibition of GnRH-stimulated FSH release) (4) . To date, we have not identified a role for inhibin in fetal adrenal function. From other studies, including in vitro assays oftesticular and ovarian steroidogenesis, it appears that inhibin alone is not active, but rather may serve as a modulator of the effects of trophic hormones (FSH and luteinizing hormone) and activin (37, 38) . Although a modulatory role for inhibin on the effects ofactivin was not observed in this study, we cannot exclude such interaction in the human fetal adrenal in vivo.
In summary, we have demonstrated that activin-A is expressed in steroidogenic adrenocortical cells in the human fetal adrenal gland, is regulated by ACTH and cAMP, and can inhibit mitogenesis while enhancing ACTH-stimulated cortisol synthesis, a marker ofdifferentiated function in fetal zone cells. Thus, activin-A may be an autocrine or paracrine factor involved in modulating growth and differentiated function in the human fetal adrenal gland.
